Literature DB >> 26077438

Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith-Wiedemann Syndrome: Clinical Spectrum and Functional Characterization.

Frederic Brioude1,2,3, Irène Netchine1,2,3, Francoise Praz1,3, Marilyne Le Jule2, Claire Calmel3, Didier Lacombe4,5, Patrick Edery6,7, Martin Catala8,9, Sylvie Odent10,11, Bertrand Isidor12,13, Stanislas Lyonnet14,15, Sabine Sigaudy16, Bruno Leheup17,18, Séverine Audebert-Bellanger19, Lydie Burglen20,21, Fabienne Giuliano22, Jean-Luc Alessandri23, Valérie Cormier-Daire24,25, Fanny Laffargue26, Sophie Blesson27, Isabelle Coupier28, James Lespinasse29, Patricia Blanchet30, Odile Boute31, Clarisse Baumann32, Michel Polak33,34, Berenice Doray35, Alain Verloes32, Géraldine Viot36, Yves Le Bouc1,2,3, Sylvie Rossignol3,35.   

Abstract

Beckwith-Wiedemann syndrome (BWS) is an imprinting disorder associating macroglossia, abdominal wall defects, visceromegaly, and a high risk of childhood tumor. Molecular anomalies are mostly epigenetic; however, mutations of CDKN1C are implicated in 8% of cases, including both sporadic and familial forms. We aimed to describe the phenotype of BWS patients with CDKN1C mutations and develop a functional test for CDKN1C mutations. For each propositus, we sequenced the three exons and intron-exon boundaries of CDKN1C in patients presenting a BWS phenotype, including abdominal wall defects, without 11p15 methylation defects. We developed a functional test based on flow cytometry. We identified 37 mutations in 38 pedigrees (50 patients and seven fetuses). Analysis of parental samples when available showed that all mutations tested but one was inherited from the mother. The four missense mutations led to a less severe phenotype (lower frequency of exomphalos) than the other 33 mutations. The following four tumors occurred: one neuroblastoma, one ganglioneuroblastoma, one melanoma, and one acute lymphoid leukemia. Cases of BWS caused by CDKN1C mutations are not rare. CDKN1C sequencing should be performed for BWS patients presenting with abdominal wall defects or cleft palate without 11p15 methylation defects or body asymmetry, or in familial cases of BWS.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  Beckwith-Wiedemann; CDKN1C; cell cycle; imprinting; overgrowth syndrome

Mesh:

Substances:

Year:  2015        PMID: 26077438     DOI: 10.1002/humu.22824

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

Review 1.  Silver-Russell Syndrome and Beckwith-Wiedemann Syndrome: Opposite Phenotypes with Heterogeneous Molecular Etiology.

Authors:  Katrin Õunap
Journal:  Mol Syndromol       Date:  2016-07-06

2.  Ongoing Challenges in the Diagnosis of 11p15.5-Associated Imprinting Disorders.

Authors:  Deborah J G Mackay; I Karen Temple
Journal:  Mol Diagn Ther       Date:  2022-05-06       Impact factor: 4.074

Review 3.  Comprehensive genetic testing approaches as the basis for personalized management of growth disturbances: current status and perspectives.

Authors:  Danielle Christine Maria van der Kaay; Anne Rochtus; Gerhard Binder; Ingo Kurth; Dirk Prawitt; Irène Netchine; Gudmundur Johannsson; Anita C S Hokken-Koelega; Miriam Elbracht; Thomas Eggermann
Journal:  Endocr Connect       Date:  2022-10-10       Impact factor: 3.221

Review 4.  Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.

Authors:  Frédéric Brioude; Jennifer M Kalish; Alessandro Mussa; Alison C Foster; Jet Bliek; Giovanni Battista Ferrero; Susanne E Boonen; Trevor Cole; Robert Baker; Monica Bertoletti; Guido Cocchi; Carole Coze; Maurizio De Pellegrin; Khalid Hussain; Abdulla Ibrahim; Mark D Kilby; Malgorzata Krajewska-Walasek; Christian P Kratz; Edmund J Ladusans; Pablo Lapunzina; Yves Le Bouc; Saskia M Maas; Fiona Macdonald; Katrin Õunap; Licia Peruzzi; Sylvie Rossignol; Silvia Russo; Caroleen Shipster; Agata Skórka; Katrina Tatton-Brown; Jair Tenorio; Chiara Tortora; Karen Grønskov; Irène Netchine; Raoul C Hennekam; Dirk Prawitt; Zeynep Tümer; Thomas Eggermann; Deborah J G Mackay; Andrea Riccio; Eamonn R Maher
Journal:  Nat Rev Endocrinol       Date:  2018-01-29       Impact factor: 43.330

5.  Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification.

Authors:  Yanna Cao; Yan Jin; Jinpu Yu; Jingfu Wang; Yanli Qiu; Xiaofeng Duan; Yingnan Ye; Yanan Cheng; Li Dong; Xiaolong Feng; Daowei Wang; Zhongyuan Li; Xiangdong Tian; Huijuan Wang; Jie Yan; Qiang Zhao
Journal:  Oncotarget       Date:  2017-07-25

6.  EMQN best practice guidelines for the molecular genetic testing and reporting of chromosome 11p15 imprinting disorders: Silver-Russell and Beckwith-Wiedemann syndrome.

Authors:  Katja Eggermann; Jet Bliek; Frédéric Brioude; Elizabeth Algar; Karin Buiting; Silvia Russo; Zeynep Tümer; David Monk; Gudrun Moore; Thalia Antoniadi; Fiona Macdonald; Irène Netchine; Paolo Lombardi; Lukas Soellner; Matthias Begemann; Dirk Prawitt; Eamonn R Maher; Marcel Mannens; Andrea Riccio; Rosanna Weksberg; Pablo Lapunzina; Karen Grønskov; Deborah Jg Mackay; Thomas Eggermann
Journal:  Eur J Hum Genet       Date:  2016-05-11       Impact factor: 4.246

7.  Variable Expressivity of the Beckwith-Wiedemann Syndrome in Four Pedigrees Segregating Loss-of-Function Variants of CDKN1C.

Authors:  Angela Sparago; Flavia Cerrato; Laura Pignata; Francisco Cammarata-Scalisi; Livia Garavelli; Carmelo Piscopo; Alessandra Vancini; Andrea Riccio
Journal:  Genes (Basel)       Date:  2021-05-09       Impact factor: 4.096

Review 8.  Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci.

Authors:  Thomas Eggermann; Guiomar Perez de Nanclares; Eamonn R Maher; I Karen Temple; Zeynep Tümer; David Monk; Deborah J G Mackay; Karen Grønskov; Andrea Riccio; Agnès Linglart; Irène Netchine
Journal:  Clin Epigenetics       Date:  2015-11-14       Impact factor: 6.551

Review 9.  Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.

Authors:  Emanuela Stampone; Ilaria Caldarelli; Alberto Zullo; Debora Bencivenga; Francesco Paolo Mancini; Fulvio Della Ragione; Adriana Borriello
Journal:  Int J Mol Sci       Date:  2018-04-02       Impact factor: 5.923

Review 10.  Exosomes of pasteurized milk: potential pathogens of Western diseases.

Authors:  Bodo C Melnik; Gerd Schmitz
Journal:  J Transl Med       Date:  2019-01-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.